Duration
30h Th
Number of credits
| Master in biomedicine (120 ECTS) | 4 crédits |
Lecturer
Language(s) of instruction
French language
Organisation and examination
Teaching in the first semester, review in January
Schedule
Units courses prerequisite and corequisite
Prerequisite or corequisite units are presented within each program
Learning unit contents
This course describes the pharmacological basis of therapeutics. Each chapter begins with a short description of pathophysiology. Therapeutic targets and the drugs acting on them are highlighted. Novel directions in therapeutic strategy may also be described.
Learning outcomes of the learning unit
At the end of this course, the students are supposed:
- To know the main targets of drugs that are used in therapeutics,
- To understand why it is interesting to act on such targets,
- To be able to give a few examples of drugs that are used clinically,
- To describe innovative strategies for the discovery of new drugs.
Prerequisite knowledge and skills
Notions of general pharmacology, physiology and pathophysiology.
Planned learning activities and teaching methods
Lectures
Mode of delivery (face to face, distance learning, hybrid learning)
Face to face
Organisational adjustments related to the current health context
Depending on the context, the teaching may become hybrid (face-to-face or online) or full online. Recordings will be made available if necessary.
Recommended or required readings
A copy of all the slides displayed during the lectures is available. Textbooks are indicated.
Assessment methods and criteria
Below you will find information on the evaluation methods planned for in-person and remote exams as well as those planned for hybrid sessions. Depending on how the health crisis evolves, the chosen method will be communicated to you no later than one month before the start of the exam session.
Oral exam consisting of two general questions, that the student can prepare during twenty minutes, as well as three short questions.
The exam may be organized online (following similar format). Ths will depend on the evolution of the sanitary context.
Work placement(s)
None
Organizational remarks
Contacts
Dr. Julien Hanson, Ph.D.
F.R.S.-FNRS Research Associate
Laboratory of Molecular Pharmacology
GIGA-Molecular Biology of Diseases
&
Medicinal Chemistry
Drug Research Centre (CIRM)
University of Liege
CHU, B34, Tour GIGA (+4)
1, av. de l'Hopital
B-4000 Liege
Belgium
Phone: +3243664748
Fax: +3243664362
e-mail : J.Hanson@uliege.be